402 related articles for article (PubMed ID: 26134756)
1. Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.
Ali MH; Messiha BA; Abdel-Latif HA
Pharm Biol; 2016 Jul; 54(7):1198-208. PubMed ID: 26134756
[TBL] [Abstract][Full Text] [Related]
2. Epigallocatechin gallate attenuated non-alcoholic steatohepatitis induced by methionine- and choline-deficient diet.
Ding Y; Sun X; Chen Y; Deng Y; Qian K
Eur J Pharmacol; 2015 Aug; 761():405-12. PubMed ID: 25967348
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression.
Abd El-Haleim EA; Bahgat AK; Saleh S
World J Gastroenterol; 2016 Mar; 22(10):2931-48. PubMed ID: 26973390
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease.
Jorgačević B; Mladenović D; Ninković M; Prokić V; Stanković MN; Aleksić V; Cerović I; Vukićević RJ; Vučević D; Stanković M; Radosavljević T
Hum Exp Toxicol; 2014 Jul; 33(7):701-9. PubMed ID: 24130212
[TBL] [Abstract][Full Text] [Related]
6. S-Propargyl-cysteine Exerts a Novel Protective Effect on Methionine and Choline Deficient Diet-Induced Fatty Liver via Akt/Nrf2/HO-1 Pathway.
Li W; Ma F; Zhang L; Huang Y; Li X; Zhang A; Hou C; Zhu Y; Zhu Y
Oxid Med Cell Longev; 2016; 2016():4690857. PubMed ID: 27313828
[TBL] [Abstract][Full Text] [Related]
7. Butein protects the nonalcoholic fatty liver through mitochondrial reactive oxygen species attenuation in rats.
Alshammari GM; Balakrishnan A; Chinnasamy T
Biofactors; 2018 May; 44(3):289-298. PubMed ID: 29672963
[TBL] [Abstract][Full Text] [Related]
8. Hepatoprotective and antioxidant activities of extracts from Salvia-Nelumbinis naturalis against nonalcoholic steatohepatitis induced by methionine- and choline-deficient diet in mice.
Liu Y; Song H; Wang L; Xu H; Shu X; Zhang L; Li Y; Li D; Ji G
J Transl Med; 2014 Nov; 12():315. PubMed ID: 25406833
[TBL] [Abstract][Full Text] [Related]
9. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
10. Caffeine affects HFD-induced hepatic steatosis by multifactorial intervention.
Helal MG; Ayoub SE; Elkashefand WF; Ibrahim TM
Hum Exp Toxicol; 2018 Sep; 37(9):983-990. PubMed ID: 29249184
[TBL] [Abstract][Full Text] [Related]
11. Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat.
Jiang W; Guo MH; Hai X
World J Gastroenterol; 2016 Dec; 22(46):10180-10188. PubMed ID: 28028366
[TBL] [Abstract][Full Text] [Related]
12. Effects of
Ghaeni Pasavei A; Mohebbati R; Jalili-Nik M; Mollazadeh H; Ghorbani A; Nosrati Tirkani A; Taraz Jamshidi S; Hashemy SI; Heidarian Miri H; Soukhtanloo M
Drug Chem Toxicol; 2021 Jan; 44(1):75-83. PubMed ID: 33319629
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol ameliorates hepatic steatosis and inflammation in methionine/choline-deficient diet-induced steatohepatitis through regulating autophagy.
Ji G; Wang Y; Deng Y; Li X; Jiang Z
Lipids Health Dis; 2015 Oct; 14():134. PubMed ID: 26498332
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholyl lysophosphatidylethanolamide improves steatosis and inflammation in murine models of nonalcoholic fatty liver disease.
Pathil A; Mueller J; Warth A; Chamulitrat W; Stremmel W
Hepatology; 2012 May; 55(5):1369-78. PubMed ID: 22183915
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of curcumin and ursodexycholic acid on non-alcoholic fatty liver disease.
Gheibi S; Gouvarchin Ghaleh HE; Motlagh BM; Azarbayjani AF; Zarei L
Biomed Pharmacother; 2019 Jul; 115():108938. PubMed ID: 31071511
[TBL] [Abstract][Full Text] [Related]
16. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
[TBL] [Abstract][Full Text] [Related]
17. Altered distribution of regulatory lymphocytes by oral administration of soy-extracts exerts a hepatoprotective effect alleviating immune mediated liver injury, non-alcoholic steatohepatitis and insulin resistance.
Khoury T; Ben Ya'acov A; Shabat Y; Zolotarovya L; Snir R; Ilan Y
World J Gastroenterol; 2015 Jun; 21(24):7443-56. PubMed ID: 26139990
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 polyunsaturated fatty acid and ursodeoxycholic acid have an additive effect in attenuating diet-induced nonalcoholic steatohepatitis in mice.
Kim JK; Lee KS; Lee DK; Lee SY; Chang HY; Choi J; Lee JI
Exp Mol Med; 2014 Dec; 46(12):e127. PubMed ID: 25523099
[TBL] [Abstract][Full Text] [Related]
19. The Synergistic Protective Effect of γ-Oryzanol (OZ) and N-Acetylcysteine (NAC) against Experimentally Induced NAFLD in Rats Entails Hypoglycemic, Antioxidant, and PPARα Stimulatory Effects.
Alwadani AH; Almasri SA; Aloud AA; Albadr NA; Alshammari GM; Yahya MA
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615764
[TBL] [Abstract][Full Text] [Related]
20. Effects of N-acetylcysteine on alcohol abstinence and alcohol-induced adverse effects in rats.
Ferreira Seiva FR; Amauchi JF; Ribeiro Rocha KK; Souza GA; Ebaid GX; Burneiko RM; Novelli EL
Alcohol; 2009 Mar; 43(2):127-35. PubMed ID: 19251114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
